| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33568033_HAS_TOPIC_C0061751> <https://research.tib.eu/covid-19/entity/33568033_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33568033_HAS_TOPIC_C0163042> <https://research.tib.eu/covid-19/entity/33568033_HAS_TOPIC_C0243370> <https://research.tib.eu/covid-19/entity/33568033_HAS_TOPIC_C1956193> <https://research.tib.eu/covid-19/entity/33568033_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33568033_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33568033_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL, United States.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Al-Kamel_Habeb> <https://research.tib.eu/covid-19/entity/Grundmann_Oliver>
?:doi	10.2174/1389557521666210210160237
?:doi	<https://research.tib.eu/covid-19/entity/10.2174/1389557521666210210160237>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Review>
?:journal	Mini reviews in medicinal chemistry
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33568033> <https://research.tib.eu/covid-19/entity/8ov6pah9>
?:pmid	<https://research.tib.eu/covid-19/entity/33568033>
?:pmid	33568033
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C2756786_TREATS_C3714514>
?:title	Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID-19).
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33568033>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33568033>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all